0 Commenti
0 condivisioni
560 Views
0 Anteprima
Cerca
Scopri nuove persone e i loro amici a quattro zampe, e fai nuove amicizie
- Effettua l'accesso per mettere mi piace, condividere e commentare!
- Comprehensive Analysis of the Global Neurodegenerative Disease MarketThe Global Neurodegenerative Disease Market Size is Anticipated to Exceed USD 90.10 Billion by 2033, Growing at a CAGR of 7.84% from 2023 to 2033. The Global Neurodegenerative Disease Market is undergoing significant growth, with projections indicating that it will exceed USD 90.10 billion by 2033. This growth is anticipated at a CAGR of 7.84% from 2023 to 2033,...0 Commenti 0 condivisioni 197 Views 0 Anteprima
- Neurodegenerative Disease Market Size, Share, Trends, Opportunities, Key Drivers and Growth ProspectusThe global Neurodegenerative Disease market size reached USD 52.03 billion in 2023. Looking forward, Analytica Global expects the market to reach USD 102.6 billion by 2032, exhibiting a growth rate (CAGR) of 7.4% during 2024-2032. Analytica Global Research newly added a research report on the Global Neurodegenerative Disease Market, which represents a study for the period from 2024 to...0 Commenti 0 condivisioni 631 Views 0 Anteprima
- Olivopontocerebellar Atrophy (OPCA) Market Expands with Advancements in Neurodegenerative Disease Research"Olivopontocerebellar Atrophy (OPCA) Market Size And Forecast by 2031 Global Olivopontocerebellar Atrophy (OPCA) market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing at a healthy CAGR of 4.20% in the above-mentioned research forecast period. Olivopontocerebellar Atrophy (OPCA) Market research report...0 Commenti 0 condivisioni 36 Views 0 Anteprima
- Patient-Centric Approaches: Shaping the Future of Neurodegenerative Disease MarketThe report presents detailed information regarding the prominent players and potential competitors in the Neurodegenerative Disease Market. It includes comprehensive insights into their worldwide presence, economic performance, strategies, upcoming product releases, research and development initiatives. Additionally, the report analyses revenue share and contact details for each player.This...0 Commenti 0 condivisioni 498 Views 0 Anteprima
- Friedreich's Ataxia: Unraveling the Mysteries of an Inherited Neurodegenerative Condition A Fresh PerspectiveWhat is Friedreich's Ataxia? FDRA (FA) is an inherited neurodegenerative disorder that causes progressive loss of coordination and balance. It affects the nerve cells in the brain and spinal cord. The most common early symptoms are problems with walking and balance that slowly worsen over time. FA is typically diagnosed in childhood or early adulthood. Friedreich's Ataxia is an autosomal...0 Commenti 0 condivisioni 172 Views 0 Anteprima
- Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Is Estimated To Witness High Growth Owing To Rising Prevalence of ALS & Increasing R&D InvestmentsThe Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market is estimated to be valued at US$662.3 million in 2023 and is expected to exhibit a CAGR of 4.6% over the forecast period from 2023 to 2030, according to a new report published by Coherent Market Insights.Market Overview:The Amyotrophic Lateral Sclerosis (ALS) Treatment Market deals with the development and commercialization of...0 Commenti 0 condivisioni 1938 Views 0 Anteprima
- Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Is Estimated To Witness High Growth Owing To Rising Prevalence of ALS & Increasing R&D InvestmentsThe Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market is estimated to be valued at US$662.3 million in 2023 and is expected to exhibit a CAGR of 4.6% over the forecast period from 2023 to 2030, according to a new report published by Coherent Market Insights.Market Overview:The Amyotrophic Lateral Sclerosis (ALS) Treatment Market deals with the development and commercialization of...0 Commenti 0 condivisioni 1845 Views 0 Anteprima
- Multiple Sclerosis Therapeutics: Recent Advances in Therapeutics for Multiple SclerosisMultiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system that damages myelin, the protective sheath surrounding nerve fibers of the brain, spinal cord, and optic nerves. This damage disrupts communication between the brain and other parts of the body. MS destroys myelin and the myelin-forming cells (oligodendrocytes) and in some cases also attacks the axons...0 Commenti 0 condivisioni 422 Views 0 Anteprima
- The Global Memantine Market Growth Is driven by rising prevalence of Alzheimer's diseaseThe memantine market overview involves neuroprotective properties of memantine for treatment of moderate to severe forms of Alzheimer's disease. Memantine is an NMDA receptor antagonist approved as an add-on therapy to cholinesterase inhibitors for patients with moderate to severe Alzheimer's disease. It regulates glutamate activity to inhibit neurotoxicity and protect neurons from...0 Commenti 0 condivisioni 717 Views 0 Anteprima
Pagine in Evidenza